改造的止血多肽及其运用制造技术

技术编号:6081747 阅读:212 留言:0更新日期:2012-04-11 18:40
本发明专利技术涉及生物蛋白质领域,特别涉及改造的止血多肽及其运用,改造的止血多肽在一个赖氨酸构成的树状核心的分枝上连接有二聚体A和二聚体B,二聚体A由如SEQIDNO:1所示的多肽和SEQIDNO:2所示的多肽依次串联而成,二聚体B由如SEQIDNO:3所示的多肽和SEQIDNO:2所示的多肽依次串联而成,其赖氨酸构成的树状核心同SEQIDNO:2所示的多肽的末端缬氨酸连接;本改造的止血多肽可用于制备止血药物;其止血效果优于如SEQIDNO:1、SEQIDNO:2和SEQIDNO:3氨基酸序列所示的止血多肽,其稳定性更佳;在使用相同剂量的情况下,其凝血效果更好。

Modified hemostatic polypeptides and uses thereof

The present invention relates to the field of biological protein, polypeptide and its use in particular to hemostatic transformation, transformation of the tree core hemostasis in a polypeptide composed of branched lysine with two dimers A and two dimers B, two peptide dimers A as shown by as shown in the SEQIDNO:1 polypeptide and SEQIDNO:2 are connected in series a two mer B peptide as shown by as shown in the SEQIDNO:3 polypeptide and SEQIDNO:2 are connected in series to the end of valine lysine core polypeptide dendrimers consisting of the same SEQIDNO:2 shows the connection; the transformation of the hemostatic polypeptide can be used for the preparation of hemostatic drugs; hemostatic hemostatic effect is better than shown in the polypeptide such as SEQIDNO:1, SEQIDNO:2 and SEQIDNO:3 amino acid sequence, its stability is better; when using the same dose, the coagulation effect is better.

【技术实现步骤摘要】

【技术保护点】
1.改造的止血多肽,其特征在于:在由一个赖氨酸构成的树状核心的分枝上连接有二聚体A和二聚体B,所述二聚体A由如SEQ ID NO:1所示的多肽和SEQ ID NO:2所示的多肽依次串联而成,所述二聚体B由如SEQ ID NO:3所示的多肽和SEQ ID NO:2所示的多肽依次串联而成,所述改造的止血多肽的赖氨酸构成的树状核心同SEQ ID NO:2所示的多肽的末端缬氨酸连接。

【技术特征摘要】

【专利技术属性】
技术研发人员:杨霞吴玉章李晋涛
申请(专利权)人:中国人民解放军第三军医大学
类型:发明
国别省市:85

网友询问留言 已有0条评论
  • 还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。

1